Bitcoin, Ether Recover Ahead of Blockbuster Anthropic Debut — Update
By Joseph Wilkins
Bitcoin and ether rebounded Thursday ahead of Anthropic's blockbuster Wall Street debut, after slipping earlier following the release of the minutes of the Federal Reserve's hawkish October meeting.
Bitcoin was 2.5% higher at $63,829 after tumbling as low as $62,086 in the previous session, while ether rose 2.4% to $1,805.39. The minutes showed that almost all Fed officials supported further rate hikes, with a handful considering an increase of half a percentage point in December.
Rate hikes increase the opportunity cost of holding nonyielding assets, including cryptocurrencies, as bonds become relatively more attractive. Traders are pricing a 90% chance of a quarter-point hike in December, with a 10% chance of a half-point rise, according to CME FedWatch.
Meanwhile, most investors who bought bitcoin ETFs in the third quarter are significantly underwater, according to cryptocurrency exchange Bitfinex Alpha. Over 90% of the inflows into bitcoin ETFs in the third quarter arrived between Aug. 17 and Sept. 25 at an average entry price of around $80,070. Buyers in that window are down about 19%, Bitfinex wrote, adding that those investors mostly comprise wealth management clients of large banks and hedge funds.
Crypto investors now turn to Anthropic's blockbuster Wall Street debut, with the company's shares expected to list Thursday. Some market participants attributed bitcoin's prior slide to investors channeling funds out of crypto assets and into the Claude developer's flotation.
"Given the investment profile, this type of allocation usually falls in the same bucket as bitcoin, and it would be consistent with investors selling bitcoin into weakness to make room," said Mauricio Di Bartolomeo, co-founder of bitcoin lending platform Ledn.
Write to Joseph Wilkins at joseph.wilkins@wsj.com
(END) Dow Jones Newswires
November 19, 2026 08:31 ET (13:31 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular

5 Stocks to Buy After Earnings

7 Undervalued Stocks That Crushed Earnings

The 10 Best Dividend Stocks

This Newly Undervalued Stock Has Plenty of Growth Ahead

